Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly A McGuigan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The American Journal of Managed Care|March 17, 2009
The effects of antihypertensive step-therapy protocols on pharmaceutical and medical utilization and expendituresTami L Mark, Teresa B Gibson, Kimberly A McGuigan
Medical Care|May 24, 2005
Impact of medication adherence on hospitalization risk and healthcare costMichael C Sokol, Kimberly A McGuigan, Robert R Verbrugge, et al.
Health Affairs (Project Hope)|June 8, 2006
Evidence-based coverage decisions? Primum non nocereNewell E McElwee, S Yin Ho, Kimberly A McGuigan, et al.
The American Journal of Managed Care|September 12, 2006
The effects of prescription drug copayments on statin adherenceTeresa B Gibson, Tami L Mark, Kimberly A McGuigan, et al.
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Mail-order prescriptions requiring clarification contact with the prescriber: prevalence, reasons, and implicationsRichard A Feifer, Linda M Nevins, Kimberly A McGuigan, et al.
Health Services Research|September 14, 2007
The effect of three-tier formulary adoption on medication continuation and spending among elderly retireesHaiden A Huskamp, Patricia A Deverka, Mary Beth Landrum, et al.
The American Journal of Managed Care|December 19, 2006
Impact of statin copayments on adherence and medical care utilization and expendituresTeresa B Gibson, Tami L Mark, Kirsten Axelsen, et al.
The New England Journal of Medicine|December 6, 2003
The effect of incentive-based formularies on prescription-drug utilization and spendingHaiden A Huskamp, Patricia A Deverka, Arnold M Epstein, et al.
Archives of General Psychiatry|April 6, 2005
Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in childrenHaiden A Huskamp, Patricia A Deverka, Arnold M Epstein, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The American Journal of Managed Care|March 17, 2009
The effects of antihypertensive step-therapy protocols on pharmaceutical and medical utilization and expendituresTami L Mark, Teresa B Gibson, Kimberly A McGuigan
Medical Care|May 24, 2005
Impact of medication adherence on hospitalization risk and healthcare costMichael C Sokol, Kimberly A McGuigan, Robert R Verbrugge, et al.
Health Affairs (Project Hope)|June 8, 2006
Evidence-based coverage decisions? Primum non nocereNewell E McElwee, S Yin Ho, Kimberly A McGuigan, et al.
The American Journal of Managed Care|September 12, 2006
The effects of prescription drug copayments on statin adherenceTeresa B Gibson, Tami L Mark, Kimberly A McGuigan, et al.
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Mail-order prescriptions requiring clarification contact with the prescriber: prevalence, reasons, and implicationsRichard A Feifer, Linda M Nevins, Kimberly A McGuigan, et al.
Health Services Research|September 14, 2007
The effect of three-tier formulary adoption on medication continuation and spending among elderly retireesHaiden A Huskamp, Patricia A Deverka, Mary Beth Landrum, et al.
The American Journal of Managed Care|December 19, 2006
Impact of statin copayments on adherence and medical care utilization and expendituresTeresa B Gibson, Tami L Mark, Kirsten Axelsen, et al.
The New England Journal of Medicine|December 6, 2003
The effect of incentive-based formularies on prescription-drug utilization and spendingHaiden A Huskamp, Patricia A Deverka, Arnold M Epstein, et al.
Archives of General Psychiatry|April 6, 2005
Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in childrenHaiden A Huskamp, Patricia A Deverka, Arnold M Epstein, et al.
Pageof 1